Last reviewed · How we verify

FK949E — Competitive Intelligence Brief

FK949E (FK949E) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Selective Androgen Receptor Modulator (SARM). Area: Musculoskeletal / Endocrinology.

phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR) Musculoskeletal / Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

FK949E (FK949E) — Astellas Pharma Inc. FK949E is a selective androgen receptor modulator (SARM) that binds to androgen receptors to promote anabolic effects while minimizing androgenic side effects.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
FK949E TARGET FK949E Astellas Pharma Inc phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR)
SAR231893 SAR231893 Sanofi marketed Selective androgen receptor modulator (SARM) Androgen receptor (AR)
MT-6548 MT-6548 Tanabe Pharma Corporation phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR)
DWJ1319 DWJ1319 Daewoong Pharmaceutical Co. LTD. phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR)
DFD-03 DFD-03 Dr. Reddy's Laboratories Limited phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR)
Org 50081 Org 50081 Merck Sharp & Dohme LLC phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR)
HGP0608 HGP0608 Hanmi Pharmaceutical Company Limited phase 3 Selective Androgen Receptor Modulator (SARM) Androgen Receptor (AR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Selective Androgen Receptor Modulator (SARM) class)

  1. AbbVie · 1 drug in this class
  2. Astellas Pharma Inc · 1 drug in this class
  3. Daewoong Pharmaceutical Co. LTD. · 1 drug in this class
  4. Dr. Reddy's Laboratories Limited · 1 drug in this class
  5. Hanmi Pharmaceutical Company Limited · 1 drug in this class
  6. Merck Sharp & Dohme LLC · 1 drug in this class
  7. Tanabe Pharma Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). FK949E — Competitive Intelligence Brief. https://druglandscape.com/ci/fk949e. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: